BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 13, 2010
View Archived Issues
Pharmacological profile supports evaluation of GSK-1427400 in chronic pain
Read More
INNOVATE-PCI trial data support entry of antiplatelet agent elinogrel in phase III trial
Read More
Intranasal desmopressin ineffective in relieving renal colic pain
Read More
Scientists identify susceptibility locus for HBV-related hepatocellular carcinoma
Read More
Bayer Schering claims new hepatocyte growth factor receptor inhibitors
Read More
Regeneron provides update on trials of aflibercept in metastatic colorectal cancer
Read More
New histamine H4 receptor ligand VUF-11488 to be tested in inflammation models
Read More
Positive outcome of decentralized procedure for Faes Farma's bilastine in Europe
Read More
Abbott discloses new CANP 1 inhibitors
Read More
Enanta Pharmaceuticals claims new antibacterial agents
Read More
Merck Frosst Canada presents new acyl-CoA desaturase inhibitors
Read More
Shire and Acceleron sign exclusive license agreement for ACTR-IIB molecules
Read More
Vanderbilt University claims new allosteric acetylcholine M1 receptor agonists
Read More
Anchor Therapeutics and Ortho-McNeil-Janssen to codevelop GPCR-targeted drugs
Read More
Daiichi Sankyo's laninamivir is approved for influenza treatment in Japan
Read More
Mymetics' HIV vaccine to enter preclinical study in primates
Read More
Marshall Edwards to acquire Novogen's isoflavone-related intellectual property
Read More
SciMeDent completes acquisition of DiabetRX
Read More
Bristol-Myers Squibb initiates tender offer to acquire ZymoGenetics
Read More
Debiopharm and Aurigene nominate Debio-0617 as development candidate
Read More
FDA approves new 500-mg dose of Faslodex
Read More
Phase I data presented on VGX-3100 in HPV-linked cervical dysplasia and cancer
Read More
RedHill Biopharma completes transactions for drugs in late-stage clinical development
Read More
Genmab reports phase II data on ofatumumab in multiple sclerosis
Read More